Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Study

19/11/2024 3 min

Author: Strober J, et al.Overview Provided by Nicolas Silvestri, MD

More episodes of the podcast Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM

Wrap Up 19/11/2024

Long-Term Safety and Efficacy of Zilucoplan in Generalized Myasthenia Gravis 120-Week Interim Analysis of RAISE-XT 19/11/2024

Cyclic and Every-Other-Week Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis Part A of ADAPT NXT 19/11/2024

Introduction 19/11/2024